Sampling of completed projects (by sector and company)

      Pharmaceuticals/Biotechnology

Abbott Laboratories, AbbVie, Acceleron Pharma, Algobiotech, Amgen, Argenx BV, Aridis Pharmaceuticals, Aspen Pharma, AstraZeneca, B&O Pharm, Bayer, Biogen, BioMérieux, Bristol-Myers Squibb, Catalent, Cenexi, Charles River, Clovis Oncology, Comil, Delpharm, Densmore, Doselec, Essa, Fareva, Gilead Sciences, Grünenthal, Horus Pharma, Hospira, Huckert’s, Innothera, Iris Pharma, IRLAB Therapeutics, Johnson & Johnson, KEYBIO, Laboratoire Aguettant, Laboratoires Brothier, Laboratoires Jouveinal, Laboratoires S.M.B., Lilly, MedTrace Pharma, Merck, Moderna, Mylan, Nektar Therapeutics, Novartis, O4CP, Pfizer, Pierre Fabre, Promepla SA, ProPharma, Replimune, Roche, Rottendorf Pharma, Sanofi-Aventis, SCHOTT, Takeda, Tesaro, Teva Pharmaceuticals, Thermo Fisher Scientific, Upjohn, Viatris, Wave Life Sciences, Worldwide Clinical Trials, Wyeth Pharmaceuticals, Zach System S.P.A., Zambon S.P.A.

Medical/Healthcare

Accuray Europe SAS, Acteon, AEMPS (Spain),
AFMPS (Belgium), ANSM (France), ANSES, ARCSA (Ecuador), Babylon Health, Beckman
Coulter, Biotech Dental Smilers, CHU Ambroise Paré, CHU Nice, CHU Rennes, CHU
Touloise, Cleanis, COFEPRIS (Mexico), Conseil
national de l’Ordre des médecins, DIXI Medical, Edwards
Lifesciences, Elsevier Masson, EPI-PHARE, Essilor, Eureka Santé, FCI
Ophthalmics, Groupe Lépine, Hospital Clínic de Barcelona, INVIMA (Colombia),
Institut Pasteur de Lille, Laboratoires COPMED, Medtech, Ministry of Health
(Panama), Miravas, Nestle Health Science, Nexus Oncology, Reckitt Benckiser Healthcare Ltd., Sacyl, Sophysa,
SRETT Medical, Symbios (Switzerland), TAPVS, Universal Medica Group, Vygon,
Zimmer Biomet

Cosmetics

Berkem, Biotic Phocea, Clémascience, Ericson Laboratoire, Garancia,
Hormeta, Lierac Paris, Lucas Meyer, Lull Paris, Novex, Novexpert, Perron Rigot
Paris, Provital, Revitacare, Vivacy